Henry Stusnick
Analyst·RA Capital Management
Henry Stusnick is an Analyst on the Investment Team at RA Capital Management. He works with the investment team and portfolio companies to understand competitive landscapes, evaluate investment opportunities across therapeutic areas from discovery through commercialization, and advise on program and pipeline strategy. Kinaset Therapeutics lists him as a board director, and a 2026 financing announcement named him as joining Kinaset's board in connection with its Series B financing.
See the rest of Henry Stusnick's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.